The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

N.D. Prins; W.A. van der Flier; D.L. Knol; N.C. Fox; H.R. Brashear; J.S. Nye; F. Barkhof; P. Scheltens

doi:10.1186/alzrt275

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

N.D. Prins, W.A. van der Flier, D.L. Knol, N.C. Fox, H.R. Brashear, J.S. Nye, F. Barkhof, P. Scheltens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	47
Journal	Alzheimer's Research & Therapy
Volume	6
Issue number	4
DOIs	https://doi.org/10.1186/alzrt275
Publication status	Published - 2014

Access to Document

10.1186/alzrt275

Cite this

Prins, N. D., van der Flier, W. A., Knol, D. L., Fox, N. C., Brashear, H. R., Nye, J. S., Barkhof, F., & Scheltens, P. (2014). The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. Alzheimer's Research & Therapy, 6(4), [47]. https://doi.org/10.1186/alzrt275

@article{9dfe66e88ec64209ae56382564c8f619,

title = "The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial",

author = "N.D. Prins and {van der Flier}, W.A. and D.L. Knol and N.C. Fox and H.R. Brashear and J.S. Nye and F. Barkhof and P. Scheltens",

year = "2014",

doi = "10.1186/alzrt275",

language = "Undefined/Unknown",

volume = "6",

journal = "Alzheimer's Research & Therapy",

issn = "1758-9193",

publisher = "BioMed Central",

number = "4",

}

Prins, ND, van der Flier, WA, Knol, DL, Fox, NC, Brashear, HR, Nye, JS, Barkhof, F & Scheltens, P 2014, 'The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial', Alzheimer's Research & Therapy, vol. 6, no. 4, 47. https://doi.org/10.1186/alzrt275

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial. / Prins, N.D.; van der Flier, W.A.; Knol, D.L. et al.

In: Alzheimer's Research & Therapy, Vol. 6, No. 4, 47, 2014.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

AU - Prins, N.D.

AU - van der Flier, W.A.

AU - Knol, D.L.

AU - Fox, N.C.

AU - Brashear, H.R.

AU - Nye, J.S.

AU - Barkhof, F.

AU - Scheltens, P.

PY - 2014

Y1 - 2014

U2 - 10.1186/alzrt275

DO - 10.1186/alzrt275

M3 - Article

C2 - 25478019

VL - 6

JO - Alzheimer's Research & Therapy

JF - Alzheimer's Research & Therapy

SN - 1758-9193

IS - 4

M1 - 47

ER -